To compare the effects of lifestyle modifications and effect of rohitaka abhaya kashaya after virechana in managing non alcoholic fatty liver disease

An open label randomized controlled clinical study to evaluate the efficacy of Rohitaka abhaya kashaya after Virechana in the management of non- alcoholic fatty liver disease - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076457

Enrollment

Registered

2024-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with NAFLD Grade 1 and 2 (mild and moderate fatty infiltration as per USG findings). Subjects aged between 18-60 years irrespective of gender, caste, religion will be included. Subjects with written informed consent, willing to participate.

Exclusion criteria

Exclusion criteria: Subjects diagnosed with systemic diseases like uncontrolled DM and HTN and other diseases like TB, HBV, and HIV. Subjects diagnosed with Cirrhosis of liver, Jaundice, Ascites, Viral hepatitis, Alcoholic Hepatitis, and other systemic diseases that interfere with the course of study. Subjects under active administration of hepato-toxic drugs. Pregnant women and lactating mothers. Subjects not fit for virechana.

Design outcomes

Primary

Measure	Time frame
Reversal of usg findings to normal stateTimepoint: 1st week and 52nd day	—

Secondary

Measure	Time frame
Maintenance of liver healthTimepoint: 100 days	—

Countries

India

Contacts

Public ContactDr Beena M D

JSS Ayurveda Medical College and Hospital

drpbsreddy@yahoo.com9538367282

Outcome results